Specialty Pharmacy

MS patients who use cognitive remediation training program showed improvement in neuropsychological tests.

Paper device offers on-the-go inexpensive diagnosis of hepatitis C and HIV.

Numerical simulations show the long-term success of immunotherapy is dependent on random fluctuations.

Cancer tumors are unable to grow larger than 2 millimeters unless angiogenesis is present.

Top news of the day from across the health care landscape.

Pharmacists currently play a minimal role in therapeutic substitution.

MS patients have higher rates of many comorbidities except for high cholesterol.

Immune response that attacks tumors may significantly improve progression-free survival.

Potent broadly neutralizing antibody binds to HIV and causes a strong immune response.

Top news of the day from across the health care landscape.

New treatments in desperate need for glioblastoma, which is resistant to chemotherapy and radiation.

Regular exercise seen to prevent tumor growth in mice.

Treating cancer found on the eyelid creates significant challenges.

Hepatitis B tends to be more aggressive in HIV patients, increasing the risk of cirrhosis, end-stage liver disease, and hepatocellular cancer.

Gaining provider status is a complex and multifaceted objective.

Baricitinib is a Janus-kinase inhibitor that interferes with intracellular enzymes in rheumatoid arthritis.

Rapamycin may effectively treat patients with venous malformations.

Research identifies important therapeutic target in cancer treatment.

Screening for vitamin D levels vital when treating adolescents with diabetes.

Antiviral drugs can spare livers for patients with other liver diseases.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

Natalizumab has been generally considered among the most effective treatments for relapsing-remitting multiple sclerosis.

Vismodegib and sonidegib reduced advanced basal cell carcinoma tumors in 43% of patients with locally advanced disease.

Compounds derived from a drug previously investigated for the treatment of Ewing sarcoma.

Minimizing sedentary behavior offers potential benefits for people with multiple sclerosis.

TAT-CaM could potentially have a multitude of applications, including cancer treatment.

The cost of oral cancer drugs spiked six-fold within the last 14 years.